Piermont Capital Management’s West Pharmaceutical WST Stock Holding History

Piermont Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11,345	Closed	-$786K	–	286
2016 Q1	$786K	Sell	11,345 -175	-2%	-$10.5K	0.25%	107
2015 Q4	$694K	Sell	11,520 -1,060	-8%	-$63.8K	0.22%	113
2015 Q3	$681K	Hold	12,580	–	–	0.22%	109
2015 Q2	$731K	Sell	12,580 -360	-3%	-$20.1K	0.22%	111
2015 Q1	$779K	Buy	12,940 +4,380	+51%	+$233K	0.24%	107
2014 Q4	$456K	Sell	8,560 -110	-1%	-$5.5K	0.16%	110
2014 Q3	$388K	Buy	8,670 +3,870	+81%	+$164K	0.15%	113
2014 Q2	$202K	Hold	4,800	–	–	0.08%	134
2014 Q1	$211K	Hold	4,800	–	–	0.1%	121
2013 Q4	$235K	Buy	+4,800	New	+$225K	0.12%	106

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Piermont Capital Management's WST Position: Q2 2016 in Review

Piermont Capital Management sold out of West Pharmaceutical (WST) in Q2 2016, closing a stake of 11,345 shares — an estimated $786K sold.

Piermont Capital Management first reported a position in WST in Q4 2013 and held it in 10 quarters. The position peaked at $786K in Q1 2016. 289 funds tracked by Wall St. Rank hold WST as of Q2 2016.

Piermont Capital Management reported no remaining West Pharmaceutical position as of Q2 2016 after selling out during the quarter.
Piermont Capital Management sold 11,345 West Pharmaceutical shares in Q2 2016, an estimated $786K.
Piermont Capital Management first reported a position in West Pharmaceutical in Q4 2013 and held it in 10 quarters.
Piermont Capital Management's West Pharmaceutical position peaked at $786K in Q1 2016.
289 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2016.

Based on Piermont Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.